INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | ₹0.70 Cr | ₹10 Cr | ₹0.50 Cr | ₹0.50 Cr |
What is the latest Contingent Liabilities ratio of INDEGENE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹0.50 Cr |
| Mar2021 | ₹0.50 Cr |
How is Contingent Liabilities of INDEGENE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹0.70 Cr | -93.07 | |
| Mar2023 | ₹10 Cr | 1,924.05 | |
| Mar2022 | ₹0.50 Cr | 0.00 | |
| Mar2021 | ₹0.50 Cr | - | |
Compare Contingent Liabilities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,549.7 Cr | -0.1% | -1.7% | -14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -0.1% |
-1.7% |
-14% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses